Financial statements Private Label Tissue
Balance sheet data of PRIVATE LABEL TISSUE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 10 239 541,66 | 16 498 695,09 | 25 016 901,39 | 50 280 369,07 | 68 394 717,75 | 106 725 805,61 |
| A. Fixed assets | 298 845,78 | 3 722 904,27 | 7 353 127,42 | 20 746 363,56 | 18 571 828,20 | 38 659 345,21 |
| B. Current assets | 9 940 695,88 | 12 775 790,82 | 17 663 773,97 | 29 534 005,51 | 49 822 889,55 | 68 066 460,40 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 10 239 541,66 | 16 498 695,09 | 25 016 901,39 | 50 280 369,07 | 68 394 717,75 | 106 725 805,61 |
| A. Equity | 2 729 898,97 | 4 660 722,27 | 9 215 580,09 | 11 673 708,71 | 19 815 923,33 | 48 241 932,56 |
| B. Liabilities and provisions for liabilities | 7 509 642,69 | 11 837 972,82 | 15 801 321,30 | 38 606 660,36 | 48 578 794,42 | 58 483 873,05 |
| I. Long-term liabilities | - | 1 925 122,00 | 4 128 540,00 | 13 834 066,93 | 11 524 167,12 | 21 361 115,31 |
| II. Short-term liabilities | 7 497 635,51 | 9 897 711,70 | 11 639 110,04 | 24 499 499,93 | 37 036 055,22 | 37 111 753,95 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.